Reinhard Dummer

102PUBLICATIONS

520CO-AUTHORS

Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Adolescent healthPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (102)

Sort by Publication Date:

|Jun 09, 2026

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes.

|May 13, 2026

Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.

|May 04, 2026

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

|Mar 28, 2026

Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.

Andrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque

|Mar 27, 2026

Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With <i>BRAF</i> V600-Mutant Solid Tumors.

Maria Vieito, Elisa Fontana, Catherine H Han

|Mar 27, 2026

Pediatric Skin Cancer: Melanoma, Basal and Squamous Cell Carcinomas, and Dermatofibrosarcoma Protuberans.

Maiko Kato, Atsushi Otsuka, Reinhard Dummer

Pageof 17

Frequent Collaborators

23 joint publications

Mitchell Paul Levesque

21 joint publications

Paolo Antonio Ascierto

15 joint publications

Egle Ramelyte

14 joint publications

Phil Fang Cheng

13 joint publications

Dirk Schadendorf

11 joint publications

Georgina V Long

10 joint publications

Caroline Robert

8 joint publications

Piotr Rutkowski

8 joint publications

Helen J Gogas

8 joint publications

Patrick Turko

Frequent Collaborators

23 joint publications

Mitchell Paul Levesque

21 joint publications

Paolo Antonio Ascierto

15 joint publications

Egle Ramelyte

14 joint publications

Phil Fang Cheng